Abstract
We have shown that urinary taurine level may be used as a biomarker of pathological and biochemical lesions. Detection of changes in the urinary concentration of this low molecular weight metabolite indicates biochemical lesions which may also be associated with pathological damage.
Hepatotoxic compounds such as CCl4, galactosamine and thioacetamide that cause hepatic necrosis and compounds such as hydrazine and ethionine that cause fatty liver all result in elevated urinary taurine levels in rats. However compounds which do not cause liver damage, such as cycloheximide, also raise urinary taurine levels. All of these substances are known to or are believed to inhibit protein synthesis. Conversely, compounds which increase protein synthesis, such as phenobarbital and clenbuterol, significantly decrease urinary taurine levels. Compounds which interfere with hepatic GSH synthesis will also change urinary taurine levels. Thus, depletion of GSH with diethyl maleate or phorone decreases urinary taurine whereas inhibition of GSH synthesis with compounds such as buthionine sulphoximine increases urinary taurine levels.
In isolated hepatocytes in vitro, leakage of taurine occurs in response to cytotoxic compounds such as hydrazine and allyl alcohol. However, total taurine levels were increased by the hepatotoxicant CCl4. Taurine synthesis is decreased by depletion of GSH with allyl alcohol in isolated hepatocytes.
Therefore taurine levels are an important potential biomarker for biochemical lesions induced by chemicals both in vivo and in vitro, in particular changes in protein and GSH synthesis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bergmeyer, M.U., Bernt, E. and Hess, B. 1965, Lactate dehydrogenase (II 2a) In: Methods of Enzymatic Analysis (Ed. Bergmeyer, H.) Academic Press, New York, pp 736–743.
Draper, R.P., Waterfield, C.J., York, M.J. and Timbrell, J.A. 1994, The effect of the muscle toxicant 2, 3, 5, 6-Tetramethyl p-phenylenediamine (TMPD) on urinary taurine and creatine. Arch. Toxicol. 69:111–117.
Draper, R.P., Waterfield, C.J., Mason, H., Wheeler, J. and Timbrell, J.A. 1994, Study of the urinary excretion of taurine and creatine in workers exposed to solvents. Human Exp. Toxicol. 13:643.
Ellman, G.L. 1959, Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82:70–77.
Hissin, P.J. and Hilf, R. 1976, A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74:214–226.
Kocsis, J.J., Harkway, S. and Snyder, R. 1975, Biological effects of the metabolites of dimethyl sulphoxide. Ann. N. Y. Acad. Sci. 243:104–109.
Sanins, S.M., Nicholson, J.K., Elcombe, C. and Timbrell, J.A. 1990, Hepatotoxin-induced hypertaurinuria: a proton NMR study. Arch. Toxicol. 64:401–411.
Timbrell, J.A., Draper, R.P. and Waterfield, C.J. 1994, Biomarkers in Toxicology. New uses for old molecules. Toxicology and Ecotoxicology News 1:1–11.
Waterfield, C.J., Turton, J.A., Scales, M.D.C. and Timbrell, J.A. 1990, Taurine synthesis in isolated rat hepatocytes in suspension exposed to carbon tetrachloride. Biochem. Soc. Trans. 18:1218–1219.
Waterfield, C.J., Turton, J.A., Scales, D.C., and Timbrell, J.A. 1991, Taurine, a possible urinary marker of liver damage: a study of taurine excretion in carbon tetrachloride treated rats. Arch. Toxicol. 65:548–555.
Waterfield, C.J., Turton, J.A., Scales, D.C. and Timbrell, J.A. 1993, Investigations into the effects of various hepatotoxic compounds on urinary and liver taurine levels in rats. Arch. Toxicol. 67:244–254.
Waterfield, C.J., Turton, J.A., Scales, D.C. and Timbrell, J.A. 1993, Effect of various non-hepatotoxic compounds on urinary and liver taurine levels in rats. Arch. Toxicol. 67:538–546.
Waterfield, C.J., Mesquita, M., Parnham, P. and Timbrell, J.A. 1993, Taurine protects against the cytotoxicity of hydrazine, 1, 4-naphthoquinone and carbon tetrachloride in isolated rat hepatocytes. Biochem. Pharmacol. 46:589–595.
Waterfield, C.J. 1994, Determination of taurine in biological samples and isolated hepatocytes by high-performance liquid chromatography with fluorimetric detection. J. Chromatog. 657:37–45.
Waterfield, C.J., Jairath, M., Asker, D. and Timbrell, J.A. 1995, The biochemical effects of clenbuterol: With particular reference to taurine and muscle damage. Europ. J. Pharmacol. 293:141–149.
Woodman, D.D. 1988, Assessment of hepatic function and damage in animal species. J. Appl. Toxicol. 8(4), 249–254.
Yoshida, M. and Hara, I. 1985, Composition of urinary metabolites and variation of urinary taurine levels in rats injected with chlorobenzene. Ind. Health 23:239–243.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Timbrell, J.A., Waterfield, C.J. (1996). Changes in Taurine as an Indicator of Hepatic Dysfunction and Biochemical Perturbations. In: Huxtable, R.J., Azuma, J., Kuriyama, K., Nakagawa, M., Baba, A. (eds) Taurine 2. Advances in Experimental Medicine and Biology, vol 403. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0182-8_15
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0182-8_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0184-2
Online ISBN: 978-1-4899-0182-8
eBook Packages: Springer Book Archive